Britain is putting AI at the center of its defenses against biological threats. The UK government has established the AI Biosecurity Lab, or AIBL, as part of its National AI Biosecurity Initiative, committing £100 million ($134 million) to create what it calls a “world-first” institute.
The mission is ambitious: bring biosecurity and life sciences experts together with frontier AI to detect biological threats, develop vaccines and accelerate medical treatments. AIBL will operate as an independent, non-profit organization, working with public-sector organizations and academic institutions as it builds a new layer of protection against risks that could affect the UK and the wider world.
A New Mission for Frontier AI
The government says AI systems are “creating unprecedented opportunities for scientific discovery,” but it also warns that they are creating “new biological risks and could lower barriers to harmful activity.” That tension sits at the heart of AIBL’s purpose: use the same technology that can expand biotech capabilities to identify dangers before they become crises.
An AI research lab in California recently claimed to have created a virus with AI and administered it into a human patient. The virus was created to infect antibiotic-resistant bacteria rather than for anything nefarious, but the work demonstrates how frontier AI can be used for biotech purposes.
AIBL’s research will target a wide range of biological risks, including threats enabled by advances in AI. The UK government says the lab’s work will strengthen UK and global resilience, while AI Minister Kanishka Narayan described it as a “major new global institution” that will bring together “world-leading scientific expertise” to protect people from emerging biological threats.
Narayan also said the UK must “stay ahead of emerging threats, from cyber attacks to biological risks,” while building more of the critical technology its security depends on. The full details of AIBL’s role and remit are yet to emerge, and Chancellor John Healey is expected to set out further details at the Budget next week.
AI Leaders Bring Models, Credits and Expertise
The government funding is only one part of the package. OpenAI is backing AIBL with £100 million in credits, allowing the lab to access its most advanced models and computing infrastructure. Anthropic will provide £100 million in model credits, giving the initiative £200 million worth of AI model credits from the two companies.
The lab will also receive support from Google DeepSeek, while collaborating with Google DeepMind and UK AI life sciences company Basecamp Research. DeepMind’s biosecurity experts will work with AIBL on research and provide access to frontier Gemini models. Basecamp Research will contribute AI-biology models and technical expertise focused on biosecurity challenges.
- OpenAI will provide £100 million in credits for advanced models and computing infrastructure.
- Anthropic will provide £100 million in model credits.
- Google DeepMind will contribute biosecurity expertise and access to frontier Gemini models.
- Basecamp Research will provide AI-biology models and technical expertise.
- AIBL will work with public-sector organizations and academic institutions.
This structure gives the lab access to funding, models, computing infrastructure and specialist knowledge at the same time. It also places the project inside a wider effort to make AI useful for national security without leaving biological risks unchecked.
A Wider UK AI Security Package
AIBL is one element of a broader investment plan covering biological, cyber and AI-enabled threats. The UK government will provide an additional £120 million to the AI Security Institute, established in 2023 under the former Conservative government to evaluate the risks of the most advanced and powerful models.
The package also includes £60 million for a National Cyber Shield, which will use agentic AI to boost cyber-defenses, and £70 million for a National Exposure and Real-Time Vulnerability Centre, known as the NERV Centre. NERV will use AI tools to detect cyber vulnerabilities across the UK’s critical infrastructure and economy.
The cyber investments follow disruption linked to a security flaw in PHP, a popular server-side scripting language used in web development for decades. The flaw, known as php2shell, led 32 Government services to go offline temporarily as organizations worked to address the vulnerabilities. There have been no reports of successful exploits so far, while National Cyber Security Centre experts worked with OpenAI to contain the fallout.
Kanishka Narayan said the Government had used AI to uncover 500 “novel vulnerabilities” across “significant areas of the public sector.” The incident shows why the UK is connecting biosecurity and cybersecurity in one national strategy: AI can expose hidden weaknesses, but it can also help defenders find and address them.
Pressure to Turn Investment Into Capability
The wider plans include £10 million a year to understand how AI will change industry, alongside an expected extra £20.4 billion for the British Business Bank and the National Wealth Fund. The Government said the move could create more than 100,000 jobs across the country from 2028-29, including jobs in AI.
Business groups welcomed the investment, while opposition critics dismissed it as a “shopping list of projects” without a clear strategy. CBI director Jordan Cummins said firms will adopt AI faster when they trust that it is safe, secure and working in the interests of their workforce, adding that “the next priority is to broaden AI skills across the whole workforce.”
Shadow AI minister Ben Spencer called for a clear plan to access the world’s best technology and turn British strengths into international influence. He also questioned how the approach fits with the Prime Minister’s drive for EU alignment and warned against regulatory alignment that restricts access to vital US technology for defense and cybersecurity.
AIBL now gives Britain a concrete test of its AI ambitions. If the independent lab can connect advanced models with biosecurity expertise, medical research and public protection, it could shape how governments respond to biological risks in the AI era. The funding is in place, the technology partners are assembling and the next phase will define how far this world-first institution can reach.
Based on
